{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SARS-CoV-2",
      "chemical biology",
      "coronavirus",
      "drug discovery and design"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33439990",
  "DateCompleted": {
    "Year": "2021",
    "Month": "01",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1042/BCJ20200514"
    ],
    "Journal": {
      "ISSN": "1470-8728",
      "JournalIssue": {
        "Volume": "478",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Jan",
          "Day": "15"
        }
      },
      "Title": "The Biochemical journal",
      "ISOAbbreviation": "Biochem J"
    },
    "ArticleTitle": "The role of chemical biology in the fight against SARS-CoV-2.",
    "Pagination": {
      "StartPage": "157",
      "EndPage": "177",
      "MedlinePgn": "157-177"
    },
    "Abstract": {
      "AbstractText": [
        "Since late 2019, biomedical labs all over the world have been struggling to cope with the 'new normal' and to find ways in which they can contribute to the fight against COVID-19. In this unique situation where a biomedical issue dominates people's lives and the news cycle, chemical biology has a great deal to contribute. This review will describe the importance of science at the chemistry/biology interface to both understand and combat the SARS-CoV-2 pandemic."
      ],
      "CopyrightInformation": "\u00a9 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biochemistry and Biophysics, Department of Cancer Biology and Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, 422 Curie Blvd., Philadelphia, PA 19104, U.S.A."
          }
        ],
        "LastName": "Burslem",
        "ForeName": "George M",
        "Initials": "GM"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Biochem J",
    "NlmUniqueID": "2984726R",
    "ISSNLinking": "0264-6021"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "chemistry",
        "pharmacology"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Design"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Discovery"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}